USANA Health Sciences Stock Price (NYSE:USNA)

Add to My Stocks
$119.35 $4.75 (3.83%) USNA stock closing price Sep 19, 2018 (Closing)
Prev Close* : $124.1
Market Cap:
$3.01B
Day Low: $118
52 Week Low: $55.50
Open: $124
Volume: -
Day High: $124.4
52 Week High: $137.95
Dividend:
0.00

Latest Stock Market News

Latest Articles

USANA Health Sciences News - From Partners

USNA Stockcharts

View USNA PE ratio, PS ratio stocks charts and compare with peers.
USNA Chart
Note: Compare USANA Health Sciences stock price history with the index and industry peers.

USANA Health Sciences Valuation

PE ratio
(price earnings ratio)
36.39
PS ratio (
price to sales ratio
)
2.63
PB ratio (
price to book ratio
)
7.64

USANA Health Sciences Returns

ROE
(return on equity)
21%

USANA Health Sciences Financial Ratios

Asset Turnover
2.15
Receivables Turnover
-
Debt to Equity
0
Dividend Yield
0%

USNA Industry Peers

Company Price Change (%)
Avanir Pharma (AVNR)16.960 (0%)
Wuxi Pharmatech (WX)45.90.16 (0.35%)
Mannatech (MTEX)20.250.15 (0.75%)
Nu Skin Enterprises (NUS)83.191.33 (1.57%)
Nature's Sunshine Products (NATR)9.10.1 (1.11%)
Nutraceutical International (NUTR)41.80 (0%)
Avon Products (AVP)2.320.03 (1.31%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
MOLECULAR TEMPL (MTEM)6.252.15 (52.44%)
Neptune Tech. & Bio. (NEPT)4.710.44 (10.3%)
Infinity Pharma (INFI)2.310.18 (8.45%)
Pacira Pharma (PCRX)51.353.5 (7.31%)
Aratana Therapeutics (PETX)5.840.39 (7.16%)
Achaogen (AKAO)4.560.28 (6.54%)
La Jolla Pharma (LJPC)22.071.12 (5.35%)
Top gainers from Medical-Drugs industry
* As of Sep 20, 2018
CompanyPriceChange (%)
PTC Therapeutics (PTCT)45.371.82 (3.86%)
USANA Health Sciences (USNA)119.354.75 (3.83%)
Esperion Therapeutics (ESPR)45.571.69 (3.58%)
ArQule (ARQL)4.850.17 (3.39%)
Zogenix (ZGNX)47.051.6 (3.29%)
Nektar Therapeutics (NKTR)56.691.64 (2.81%)
Durect (DRRX)1.10.03 (2.65%)
Top losers from Medical-Drugs industry
* As of Sep 20, 2018

USANA Health Sciences, Inc. Stock News - Partner Headlines

USANA Health Sciences Financial Statements

income statement20172016201520142013
Net Sales or Revenues1.05B1.01B918.49M790.47M718.17M
Net Income62.53M100.04M94.67M76.63M79.02M
Total Operating Expense735.35M687.27M617.15M533.57M474.02M
View USANA Health Sciences income statement
balance sheet20172016201520142013
Total Assets519.26M470.64M423.23M350.58M368.47M
Total Liabilities156.05M145.35M142.38M120.42M107.94M
Shareholders Equity363.21M325.28M280.85M230.16M260.52M
View USANA Health Sciences balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities7.59M10.54M10.32M25.76M9.86M
Net Cash from (used by) Operating Activities123.78M137.03M111.46M105.18M98.89M
Increase (Decrease) in Prop Plant And Equipment-13.19M-32.68M-23.54M-20.41M-8M
View USANA Health Sciences cash flow statement

USANA Health Sciences Stock Message Board

USANA Health Sciences stock lost 3.83%, and the last close price as of Sep 19, 2018 is $119.35 for USNA stock. Looking at USANA Health Sciences market capitalization, which currently stands at $3.01B, we can say that USNA stock is a Mid Cap stock. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing USANA Health Sciences stock analysis.

For recognizing and analyzing the real performance of USANA Health Sciences stock, it is a standard practise to adjust historical stock prices to remove gaps caused by stock splits, dividends and distributions. 159,766 USNA shares were traded yesterday, and USANA Health Sciences stock chart shows that the USNA stock quote hit a day high of $124.4 and day low of $118. A dividend is a cash payment made from a company's earnings and is distributed among shareholders. USANA Health Sciences does not pay dividends. USANA Health Sciences stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.